[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Cetuximab Market Report 2016

November 2016 | 101 pages | ID: EC2036650B6EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Cetuximab

Revenue, means the sales value of Cetuximab

This report studies sales (consumption) of Cetuximab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Sanofi SA (France)
  • Wyeth (US)
  • GlaxoSmithKline Plc (UK)
  • Abbott Laboratories (USA)
  • Pfizer Inc. (USA)
  • Eli Lilly and Company (US)
  • Merck & Co., Inc. (US)
  • Warner Chilcott plc (Ireland)
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cetuximab in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Cetuximab in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Cetuximab Market Report 2016

1 CETUXIMAB OVERVIEW

1.1 Product Overview and Scope of Cetuximab
1.2 Classification of Cetuximab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cetuximab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Cetuximab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cetuximab (2011-2021)
  1.5.1 Europe Cetuximab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Cetuximab Revenue and Growth Rate (2011-2021)

2 EUROPE CETUXIMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Cetuximab Market Competition by Manufacturers
  2.1.1 Europe Cetuximab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Cetuximab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cetuximab (Volume and Value) by Type
  2.2.1 Europe Cetuximab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Cetuximab Revenue and Market Share by Type (2011-2016)
2.3 Europe Cetuximab (Volume and Value) by Countries
  2.3.1 Europe Cetuximab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Cetuximab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cetuximab (Volume) by Application

3 GERMANY CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Cetuximab Sales and Value (2011-2016)
  3.1.1 Germany Cetuximab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Cetuximab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Cetuximab Sales Price Trend (2011-2016)
3.2 Germany Cetuximab Sales and Market Share by Manufacturers
3.3 Germany Cetuximab Sales and Market Share by Type
3.4 Germany Cetuximab Sales and Market Share by Application

4 FRANCE CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Cetuximab Sales and Value (2011-2016)
  4.1.1 France Cetuximab Sales and Growth Rate (2011-2016)
  4.1.2 France Cetuximab Revenue and Growth Rate (2011-2016)
  4.1.4 France Cetuximab Sales Price Trend (2011-2016)
4.2 France Cetuximab Sales and Market Share by Manufacturers
4.3 France Cetuximab Sales and Market Share by Type
4.4 France Cetuximab Sales and Market Share by Application

5 UK CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Cetuximab Sales and Value (2011-2016)
  5.1.1 UK Cetuximab Sales and Growth Rate (2011-2016)
  5.1.2 UK Cetuximab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Cetuximab Sales Price Trend (2011-2016)
5.2 UK Cetuximab Sales and Market Share by Manufacturers
5.3 UK Cetuximab Sales and Market Share by Type
5.4 UK Cetuximab Sales and Market Share by Application

6 RUSSIA CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Cetuximab Sales and Value (2011-2016)
  6.1.1 Russia Cetuximab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Cetuximab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Cetuximab Sales Price Trend (2011-2016)
6.2 Russia Cetuximab Sales and Market Share by Manufacturers
6.3 Russia Cetuximab Sales and Market Share by Type
6.4 Russia Cetuximab Sales and Market Share by Application

7 ITALY CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Cetuximab Sales and Value (2011-2016)
  7.1.1 Italy Cetuximab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Cetuximab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Cetuximab Sales Price Trend (2011-2016)
7.2 Italy Cetuximab Sales and Market Share by Manufacturers
7.3 Italy Cetuximab Sales and Market Share by Type
7.4 Italy Cetuximab Sales and Market Share by Application

8 SPAIN CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Cetuximab Sales and Value (2011-2016)
  8.1.1 Spain Cetuximab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Cetuximab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Cetuximab Sales Price Trend (2011-2016)
8.2 Spain Cetuximab Sales and Market Share by Manufacturers
8.3 Spain Cetuximab Sales and Market Share by Type
8.4 Spain Cetuximab Sales and Market Share by Application

9 BENELUX CETUXIMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Cetuximab Sales and Value (2011-2016)
  9.1.1 Benelux Cetuximab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Cetuximab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Cetuximab Sales Price Trend (2011-2016)
9.2 Benelux Cetuximab Sales and Market Share by Manufacturers
9.3 Benelux Cetuximab Sales and Market Share by Type
9.4 Benelux Cetuximab Sales and Market Share by Application

10 EUROPE CETUXIMAB MANUFACTURERS ANALYSIS

10.1 Sanofi SA (France)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Cetuximab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Wyeth (US)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Cetuximab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 GlaxoSmithKline Plc (UK)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Cetuximab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories (USA)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Cetuximab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer Inc. (USA)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Cetuximab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Eli Lilly and Company (US)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Cetuximab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Merck & Co., Inc. (US)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Cetuximab Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Warner Chilcott plc (Ireland)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Cetuximab Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 CETUXIMAB MANUFACTURING COST ANALYSIS

11.1 Cetuximab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cetuximab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Cetuximab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cetuximab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE CETUXIMAB MARKET FORECAST (2016-2021)

14.1 Germany Cetuximab Sales Forecast (2016-2021)
14.2 France Cetuximab Sales Forecast (2016-2021)
14.3 UK Cetuximab Sales Forecast (2016-2021)
14.4 Russia Cetuximab Sales Forecast (2016-2021)
14.5 Italy Cetuximab Sales Forecast (2016-2021)
14.6 Spain Cetuximab Sales Forecast (2016-2021)
14.7 Benelux Cetuximab Sales Forecast (2016-2021)
14.8 Europe Cetuximab Sales Forecast by Type (2016-2021)
14.9 Europe Cetuximab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Cetuximab
Table Classification of Cetuximab
Figure Europe Sales Market Share of Cetuximab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Cetuximab
Figure Europe Sales Market Share of Cetuximab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Cetuximab Revenue and Growth Rate (2011-2021)
Figure France Cetuximab Revenue and Growth Rate (2011-2021)
Figure UK Cetuximab Revenue and Growth Rate (2011-2021)
Figure Russia Cetuximab Revenue and Growth Rate (2011-2021)
Figure Italy Cetuximab Revenue and Growth Rate (2011-2021)
Figure Spain Cetuximab Revenue and Growth Rate (2011-2021)
Figure Benelux Cetuximab Revenue and Growth Rate (2011-2021)
Figure Europe Cetuximab Sales and Growth Rate (2011-2021)
Figure Europe Cetuximab Revenue and Growth Rate (2011-2021)
Table Europe Cetuximab Sales of Key Manufacturers (2015 and 2016)
Table Europe Cetuximab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cetuximab Sales Share by Manufacturers
Figure 2016 Cetuximab Sales Share by Manufacturers
Table Europe Cetuximab Revenue by Manufacturers (2015 and 2016)
Table Europe Cetuximab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cetuximab Revenue Share by Manufacturers
Table 2016 Europe Cetuximab Revenue Share by Manufacturers
Table Europe Cetuximab Sales and Market Share by Type (2011-2016)
Table Europe Cetuximab Sales Share by Type (2011-2016)
Figure Sales Market Share of Cetuximab by Type (2011-2016)
Figure Europe Cetuximab Sales Growth Rate by Type (2011-2016)
Table Europe Cetuximab Revenue and Market Share by Type (2011-2016)
Table Europe Cetuximab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cetuximab by Type (2011-2016)
Figure Europe Cetuximab Revenue Growth Rate by Type (2011-2016)
Table Europe Cetuximab Sales and Market Share by Countries (2011-2016)
Table Europe Cetuximab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cetuximab by Countries (2011-2016)
Table Europe Cetuximab Revenue and Market Share by Countries (2011-2016)
Table Europe Cetuximab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cetuximab by Countries (2011-2016)
Table Europe Cetuximab Sales and Market Share by Application (2011-2016)
Table Europe Cetuximab Sales Share by Application (2011-2016)
Figure Sales Market Share of Cetuximab by Application (2011-2016)
Figure Germany Cetuximab Sales and Growth Rate (2011-2016)
Figure Germany Cetuximab Revenue and Growth Rate (2011-2016)
Figure Germany Cetuximab Sales Price Trend (2011-2016)
Table Germany Cetuximab Sales by Manufacturers (2015 and 2016)
Table Germany Cetuximab Market Share by Manufacturers (2015 and 2016)
Table Germany Cetuximab Sales by Type (2015 and 2016)
Table Germany Cetuximab Market Share by Type (2015 and 2016)
Table Germany Cetuximab Sales by Application (2015 and 2016)
Table Germany Cetuximab Market Share by Application (2015 and 2016)
Figure France Cetuximab Sales and Growth Rate (2011-2016)
Figure France Cetuximab Revenue and Growth Rate (2011-2016)
Figure France Cetuximab Sales Price Trend (2011-2016)
Table France Cetuximab Sales by Manufacturers (2015 and 2016)
Table France Cetuximab Market Share by Manufacturers (2015 and 2016)
Table France Cetuximab Sales by Type (2015 and 2016)
Table France Cetuximab Market Share by Type (2015 and 2016)
Table France Cetuximab Sales by Application (2015 and 2016)
Table France Cetuximab Market Share by Application (2015 and 2016)
Figure UK Cetuximab Sales and Growth Rate (2011-2016)
Figure UK Cetuximab Revenue and Growth Rate (2011-2016)
Figure UK Cetuximab Sales Price Trend (2011-2016)
Table UK Cetuximab Sales by Manufacturers (2015 and 2016)
Table UK Cetuximab Market Share by Manufacturers (2015 and 2016)
Table UK Cetuximab Sales by Type (2015 and 2016)
Table UK Cetuximab Market Share by Type (2015 and 2016)
Table UK Cetuximab Sales by Application (2015 and 2016)
Table UK Cetuximab Market Share by Application (2015 and 2016)
Figure Russia Cetuximab Sales and Growth Rate (2011-2016)
Figure Russia Cetuximab Revenue and Growth Rate (2011-2016)
Figure Russia Cetuximab Sales Price Trend (2011-2016)
Table Russia Cetuximab Sales by Manufacturers (2015 and 2016)
Table Russia Cetuximab Market Share by Manufacturers (2015 and 2016)
Table Russia Cetuximab Sales by Type (2015 and 2016)
Table Russia Cetuximab Market Share by Type (2015 and 2016)
Table Russia Cetuximab Sales by Application (2015 and 2016)
Table Russia Cetuximab Market Share by Application (2015 and 2016)
Figure Italy Cetuximab Sales and Growth Rate (2011-2016)
Figure Italy Cetuximab Revenue and Growth Rate (2011-2016)
Figure Italy Cetuximab Sales Price Trend (2011-2016)
Table Italy Cetuximab Sales by Manufacturers (2015 and 2016)
Table Italy Cetuximab Market Share by Manufacturers (2015 and 2016)
Table Italy Cetuximab Sales by Type (2015 and 2016)
Table Italy Cetuximab Market Share by Type (2015 and 2016)
Table Italy Cetuximab Sales by Application (2015 and 2016)
Table Italy Cetuximab Market Share by Application (2015 and 2016)
Figure Spain Cetuximab Sales and Growth Rate (2011-2016)
Figure Spain Cetuximab Revenue and Growth Rate (2011-2016)
Figure Spain Cetuximab Sales Price Trend (2011-2016)
Table Spain Cetuximab Sales by Manufacturers (2015 and 2016)
Table Spain Cetuximab Market Share by Manufacturers (2015 and 2016)
Table Spain Cetuximab Sales by Type (2015 and 2016)
Table Spain Cetuximab Market Share by Type (2015 and 2016)
Table Spain Cetuximab Sales by Application (2015 and 2016)
Table Spain Cetuximab Market Share by Application (2015 and 2016)
Figure Benelux Cetuximab Sales and Growth Rate (2011-2016)
Figure Benelux Cetuximab Revenue and Growth Rate (2011-2016)
Figure Benelux Cetuximab Sales Price Trend (2011-2016)
Table Benelux Cetuximab Sales by Manufacturers (2015 and 2016)
Table Benelux Cetuximab Market Share by Manufacturers (2015 and 2016)
Table Benelux Cetuximab Sales by Type (2015 and 2016)
Table Benelux Cetuximab Market Share by Type (2015 and 2016)
Table Benelux Cetuximab Sales by Application (2015 and 2016)
Table Benelux Cetuximab Market Share by Application (2015 and 2016)
Table Cetuximab Basic Information List
Table Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Cetuximab Sales Market Share (2011-2016)
Table Wyeth (US) Basic Information List
Table Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wyeth (US) Cetuximab Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Cetuximab Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Cetuximab Sales Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. (USA) Cetuximab Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Cetuximab Sales Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (US) Cetuximab Sales Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information List
Table Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Warner Chilcott plc (Ireland) Cetuximab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cetuximab
Figure Manufacturing Process Analysis of Cetuximab
Figure Cetuximab Industrial Chain Analysis
Table Raw Materials Sources of Cetuximab Major Manufacturers in 2015
Table Major Buyers of Cetuximab
Table Distributors/Traders List
Figure Germany Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure France Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure France Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure UK Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cetuximab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cetuximab Sales Forecast by Type (2016-2021)
Table Europe Cetuximab Sales Forecast by Application (2016-2021)


More Publications